Single-cell and spatial transcriptomics identify MMP1 as a contributor to extracellular matrix remodeling and invasion in lung adenocarcinoma

Matrix metallopeptidase 1 ( MMP1 ), a secreted collagenase, is linked to aggressive lung adenocarcinoma (LUAD); its cellular origin and stage-specific function remain unclear. A 39-gene metabolic reprogramming signature (MetabRisk) was derived from 1,045 lipid-metabolism genes in TCGA-LUAD, benchmarked across five screening cohorts and validated in eight independent cohorts; MMP1 was profiled for expression, prognosis, protein abundance, cell source (seven cohorts; 837,814 cells), spatial distribution and phenotype, and silenced by siRNA. MetabRisk reached an internal cross-validated C-index of 0.618 and a pooled external C-index of 0.629 (95% CI 0.605–0.652), and highlighted MMP1 . MMP1 was tumor-upregulated (log 2 FC = 4.62). At cohort-median stratification, higher expression was associated with shorter progression-free interval in TCGA-LUAD (HR = 1.31, p = 0.029) and with shorter survival in three of the five screening cohorts (p = 0.014–0.036), whereas analysis as a continuous variable was not significant in TCGA-LUAD (HR 1.02–1.08, p = 0.31–0.82); the association is therefore modest and cut-point-dependent, and single-gene survival p values are not adjusted for the number of endpoints or cohorts examined. Protein was elevated in 207 CPTAC pairs. MMP1 + spot fractions rose from pre-invasive to invasive LUAD (median 4.18%; p = 1.8 × 10 –6 ) and were ~11-fold higher among epithelial cells at the invasive edge in a descriptive, exploratory comparison of three patients; MMP1+ cells were restricted to tumor tissue and comprised malignant-epithelial and CAF fractions in proportions that varied across cohorts. Patient-matched brain metastases expressed less MMP1 than primary tumors (23 pairs, p = 0.010). MMP1 + malignant cells showed higher nuclear-encoded OXPHOS and fatty-acid-oxidation module scores; MMP1 knockdown in A549 and PC-9 cells suppressed proliferation, migration and invasion. MMP1 therefore contributes to extracellular matrix remodeling and invasion in LUAD and merits preclinical evaluation as a candidate therapeutic target in invasive-stage LUAD.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-11-17
DOI
https://doi.org/10.3389/fonc.2026.1996649
Primary Topic
Protease and Inhibitor Mechanisms
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Single-cell and spatial transcriptomics identify MMP1 as a contributor to extracellular matrix remodeling and invasion in lung adenocarcinoma

Fei Qu, Yani Hu, Zhipeng Zeng, Sen Li et al.
1 links
Frontiers in Oncology
Protease and Inhibitor Mechanisms
article

Single-cell and spatial transcriptomics identify MMP1 as a contributor to extracellular matrix remodeling and invasion in lung adenocarcinoma

Fei Qu, Yani Hu, Zhipeng Zeng, Sen Li, Bo Shen, Dong Hua, Yanping Feng, Xu Zhou, Yizhang Chen, Weijing Wang
article en

Abstract

Matrix metallopeptidase 1 ( MMP1 ), a secreted collagenase, is linked to aggressive lung adenocarcinoma (LUAD); its cellular origin and stage-specific function remain unclear. A 39-gene metabolic reprogramming signature (MetabRisk) was derived from 1,045 lipid-metabolism genes in TCGA-LUAD, benchmarked across five screening cohorts and validated in eight independent cohorts; MMP1 was profiled for expression, prognosis, protein abundance, cell source (seven cohorts; 837,814 cells), spatial distribution and phenotype, and silenced by siRNA. MetabRisk reached an internal cross-validated C-index of 0.618 and a pooled external C-index of 0.629 (95% CI 0.605–0.652), and highlighted MMP1 . MMP1 was tumor-upregulated (log 2 FC = 4.62). At cohort-median stratification, higher expression was associated with shorter progression-free interval in TCGA-LUAD (HR = 1.31, p = 0.029) and with shorter survival in three of the five screening cohorts (p = 0.014–0.036), whereas analysis as a continuous variable was not significant in TCGA-LUAD (HR 1.02–1.08, p = 0.31–0.82); the association is therefore modest and cut-point-dependent, and single-gene survival p values are not adjusted for the number of endpoints or cohorts examined. Protein was elevated in 207 CPTAC pairs. MMP1 + spot fractions rose from pre-invasive to invasive LUAD (median 4.18%; p = 1.8 × 10 –6 ) and were ~11-fold higher among epithelial cells at the invasive edge in a descriptive, exploratory comparison of three patients; MMP1+ cells were restricted to tumor tissue and comprised malignant-epithelial and CAF fractions in proportions that varied across cohorts. Patient-matched brain metastases expressed less MMP1 than primary tumors (23 pairs, p = 0.010). MMP1 + malignant cells showed higher nuclear-encoded OXPHOS and fatty-acid-oxidation module scores; MMP1 knockdown in A549 and PC-9 cells suppressed proliferation, migration and invasion. MMP1 therefore contributes to extracellular matrix remodeling and invasion in LUAD and merits preclinical evaluation as a candidate therapeutic target in invasive-stage LUAD.

Frontiers in OncologyVol. 16
Jiangnan University (CN), Wuxi Fourth People's Hospital (CN), Wuxi People's Hospital (CN), Nanjing Medical University (CN)
Jiangnan University, Nanjing Medical University, Wuxi Health and Family Planning Commission
Good health and well-being
Protease and Inhibitor Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon